Virus-based nanoparticles as platform technologies for modern vaccines
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Virus-based nanoparticles as platform technologies for modern vaccines
Authors
Keywords
-
Journal
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
Volume 8, Issue 4, Pages 554-578
Publisher
Wiley
Online
2016-01-19
DOI
10.1002/wnan.1383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pertuzumab in the Treatment of HER2+Breast Cancer
- (2017) Komal Jhaveri et al. Journal of the National Comprehensive Cancer Network
- A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses
- (2015) Amber Dunkel et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Emerging influenza viruses and the prospect of a universal influenza virus vaccine
- (2015) Florian Krammer Biotechnology Journal
- Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone
- (2015) Daniel J. Park et al. CELL
- Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses
- (2015) Mallory Willet et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
- (2015) Demetrius Matassov et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses
- (2015) Jaina M. Patel et al. Nanomedicine-Nanotechnology Biology and Medicine
- In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
- (2015) P. H. Lizotte et al. Nature Nanotechnology
- Plant Virus Particles Carrying Tumour Antigen Activate TLR7 and Induce High Levels of Protective Antibody
- (2015) Jantipa Jobsri et al. PLoS One
- An Ebola whole-virus vaccine is protective in nonhuman primates
- (2015) A. Marzi et al. SCIENCE
- Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets
- (2015) Ye V. Liu et al. VACCINE
- H5N1 influenza virus-like particle vaccine protects mice from heterologous virus challenge better than whole inactivated virus
- (2015) Zhiguang Ren et al. VIRUS RESEARCH
- Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
- (2015) Martin R Farlow et al. Alzheimers Research & Therapy
- Emerging influenza viruses and the prospect of a universal influenza virus vaccine
- (2015) Florian Krammer Biotechnology Journal
- A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types
- (2015) Bettina Huber et al. PLoS One
- Immune responses to vaccines involving a combined antigen–nanoparticle mixture and nanoparticle-encapsulated antigen formulation
- (2014) Weifeng Zhang et al. BIOMATERIALS
- The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine
- (2014) Mitchell Tyler et al. BIOTECHNOLOGY AND BIOENGINEERING
- Structural Basis for the Development of Avian Virus Capsids That Display Influenza Virus Proteins and Induce Protective Immunity
- (2014) Elena Pascual et al. JOURNAL OF VIROLOGY
- HIV infection: epidemiology, pathogenesis, treatment, and prevention
- (2014) Gary Maartens et al. LANCET
- Emergence of Zaire Ebola Virus Disease in Guinea
- (2014) Sylvain Baize et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation
- (2014) Karen A. O. Martins et al. PLoS One
- Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines
- (2014) Brian J. Ward et al. VACCINE
- Molecular farming of fluorescent virus-based nanoparticles for optical imaging in plants, human cells and mouse models
- (2014) S. Shukla et al. Biomaterials Science
- Presentation of HER2 epitopes using a filamentous plant virus-based vaccination platform
- (2014) Sourabh Shukla et al. Journal of Materials Chemistry B
- Boosting Immunity to Small Tumor-Associated Carbohydrates with Bacteriophage Qβ Capsids
- (2013) Zhaojun Yin et al. ACS Chemical Biology
- Biomimetic Antigenic Nanoparticles Elicit Controlled Protective Immune Response to Influenza
- (2013) Dustin P. Patterson et al. ACS Nano
- Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model
- (2013) Alberto Monroy-García et al. ARCHIVES OF VIROLOGY
- Bioengineering virus-like particles as vaccines
- (2013) Linda H.L. Lua et al. BIOTECHNOLOGY AND BIOENGINEERING
- Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis
- (2013) Andrea C Tricco et al. BMC Medicine
- Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1–Infected Women in Uganda (HPTN 027)
- (2013) Pontiano Kaleebu et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
- (2013) Christina Schellenbacher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1–40
- (2013) Gaifeng Feng et al. JOURNAL OF NEUROSCIENCE METHODS
- A Vaccine against CCR5 Protects a Subset of Macaques upon Intravaginal Challenge with Simian Immunodeficiency Virus SIVmac251
- (2013) K. K. A. Van Rompay et al. JOURNAL OF VIROLOGY
- Adenovirus Capsid-Based Anti-Cocaine Vaccine Prevents Cocaine from Binding to the Nonhuman Primate CNS Dopamine Transporter
- (2013) Anat Maoz et al. NEUROPSYCHOPHARMACOLOGY
- Active immunotherapy for chronic diseases
- (2013) Martin F. Bachmann et al. VACCINE
- A brief history of the global effort to develop a preventive HIV vaccine
- (2013) José Esparza VACCINE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants
- (2013) Masaaki Kawano et al. VIROLOGY
- Influenza virus hemagglutinin stalk-based antibodies and vaccines
- (2013) Florian Krammer et al. Current Opinion in Virology
- Vaccine delivery using nanoparticles
- (2013) Anthony E. Gregory et al. Frontiers in Cellular and Infection Microbiology
- Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP
- (2013) Cindy Babin et al. JOURNAL OF NANOBIOTECHNOLOGY
- Tobacco Mosaic Virus as a New Carrier for Tumor Associated Carbohydrate Antigens
- (2012) Zhaojun Yin et al. BIOCONJUGATE CHEMISTRY
- Coconfinement of Fluorescent Proteins: Spatially Enforced Communication of GFP and mCherry Encapsulated within the P22 Capsid
- (2012) Alison O’Neil et al. BIOMACROMOLECULES
- Developments in rabies vaccines
- (2012) D. J. Hicks et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Disrupted Adenovirus-Based Vaccines Against Small Addictive Molecules Circumvent Anti-Adenovirus Immunity
- (2012) Bishnu P. De et al. HUMAN GENE THERAPY
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- Induction of Protective Anti-CTL Epitope Responses against HER-2-Positive Breast Cancer Based on Multivalent T7 Phage Nanoparticles
- (2012) Somayeh Pouyanfard et al. PLoS One
- VLPs Displaying a Single L2 Epitope Induce Broadly Cross-Neutralizing Antibodies against Human Papillomavirus
- (2012) Ebenezer Tumban et al. PLoS One
- A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose
- (2012) Laura E. Richert et al. VACCINE
- Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein
- (2012) Amy B. Papaneri et al. VACCINE
- Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41
- (2012) C. Pastori et al. VIROLOGY
- A Peephole into the Brain: Neuropathological Features of Alzheimer’s Disease Revealed by in vivo Two-Photon Imaging
- (2012) Sabine Liebscher et al. Frontiers in Psychiatry
- A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae
- (2011) Shipeng Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
- (2011) Morgane Bomsel et al. IMMUNITY
- Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response
- (2011) Baidong Hou et al. IMMUNITY
- Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
- (2011) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
- (2011) J. E. Blaney et al. JOURNAL OF VIROLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cocaine Analog Coupled to Disrupted Adenovirus: A Vaccine Strategy to Evoke High-titer Immunity Against Addictive Drugs
- (2011) Martin J Hicks et al. MOLECULAR THERAPY
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Novel Cocaine Vaccine Linked to a Disrupted Adenovirus Gene Transfer Vector Blocks Cocaine Psychostimulant and Reinforcing Effects
- (2011) Sunmee Wee et al. NEUROPSYCHOPHARMACOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic vaccines for chronic diseases: successes and technical challenges
- (2011) M. F. Bachmann et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
- (2011) Ebenezer Tumban et al. PLoS One
- Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand
- (2011) Punnee Pitisuttithum et al. PLoS One
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico
- (2011) Constantino López-Macías et al. VACCINE
- Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles
- (2010) Sharmila Pejawar-Gaddy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pathology and epidemiology of HPV infection in females
- (2010) Margaret Stanley GYNECOLOGIC ONCOLOGY
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- The Art of Engineering Viral Nanoparticles
- (2010) Jonathan K. Pokorski et al. MOLECULAR PHARMACEUTICS
- Influenza Vaccines for the Future
- (2010) Linda C. Lambert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
- (2010) Alain C. Tissot et al. PLoS One
- A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
- (2009) Ursula Wiedermann et al. BREAST CANCER RESEARCH AND TREATMENT
- Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma
- (2009) Fei-Xiang Ding et al. HEPATOLOGY
- Anti-drug vaccines to treat substance abuse
- (2009) Berma M Kinsey et al. IMMUNOLOGY AND CELL BIOLOGY
- Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
- (2009) Balasubramanyam Karanam et al. IMMUNOLOGY AND CELL BIOLOGY
- Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses
- (2009) J. Bessa et al. JOURNAL OF IMMUNOLOGY
- Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes
- (2009) Rafael Cubas et al. JOURNAL OF IMMUNOTHERAPY
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years
- (2009) Cosette M. Wheeler et al. JOURNAL OF INFECTIOUS DISEASES
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge
- (2009) L. A. Perrone et al. JOURNAL OF VIROLOGY
- Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
- (2009) G. F. Arnold et al. JOURNAL OF VIROLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory Viruses
- (2009) James A. Wiley et al. PLoS One
- Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron
- (2009) A. Naskalska et al. VACCINE
- Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice
- (2009) Chiara Lico et al. VACCINE
- Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
- (2008) Gary T. Jennings et al. Annual Review of Pharmacology and Toxicology
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis
- (2008) Gunther Spohn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Epaxal®: a virosomal vaccine to prevent hepatitis A infection
- (2008) Patrick A Bovier Expert Review of Vaccines
- Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study
- (2008) Alain C Tissot et al. LANCET
- The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
- (2008) Gunilla B. Karlsson Hedestam et al. NATURE REVIEWS MICROBIOLOGY
- Influenza virus-like particles produced by transient expression inNicotiana benthamianainduce a protective immune response against a lethal viral challenge in mice
- (2008) Marc-André D’Aoust et al. PLANT BIOTECHNOLOGY JOURNAL
- Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
- (2008) Fiona M. Thompson et al. PLoS One
- Vaccination against GIP for the Treatment of Obesity
- (2008) Alma Fulurija et al. PLoS One
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform
- (2008) Jérôme Denis et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started